Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Eur J Obstet Gynecol Reprod Biol ; 276: 161-167, 2022 Sep.
Article in English | MEDLINE | ID: covidwho-2273198

ABSTRACT

OBJECTIVE: To assess perinatal outcomes for pregnancies affected by suspected or confirmed SARS-CoV-2 infection. METHODS: Prospective, web-based registry. Pregnant women were invited to participate if they had suspected or confirmed SARS-CoV-2 infection between 1st January 2020 and 31st March 2021 to assess the impact of infection on maternal and perinatal outcomes including miscarriage, stillbirth, fetal growth restriction, pre-term birth and transmission to the infant. RESULTS: Between April 2020 and March 2021, the study recruited 8239 participants who had suspected or confirmed SARs-CoV-2 infection episodes in pregnancy between January 2020 and March 2021. Maternal death affected 14/8197 (0.2%) participants, 176/8187 (2.2%) of participants required ventilatory support. Pre-eclampsia affected 389/8189 (4.8%) participants, eclampsia was reported in 40/ 8024 (0.5%) of all participants. Stillbirth affected 35/8187 (0.4 %) participants. In participants delivering within 2 weeks of delivery 21/2686 (0.8 %) were affected by stillbirth compared with 8/4596 (0.2 %) delivering ≥ 2 weeks after infection (95 % CI 0.3-1.0). SGA affected 744/7696 (9.3 %) of livebirths, FGR affected 360/8175 (4.4 %) of all pregnancies. Pre-term birth occurred in 922/8066 (11.5%), the majority of these were indicated pre-term births, 220/7987 (2.8%) participants experienced spontaneous pre-term births. Early neonatal deaths affected 11/8050 livebirths. Of all neonates, 80/7993 (1.0%) tested positive for SARS-CoV-2. CONCLUSIONS: Infection was associated with indicated pre-term birth, most commonly for fetal compromise. The overall proportions of women affected by SGA and FGR were not higher than expected, however there was the proportion affected by stillbirth in participants delivering within 2 weeks of infection was significantly higher than those delivering ≥ 2 weeks after infection. We suggest that clinicians' threshold for delivery should be low if there are concerns with fetal movements or fetal heart rate monitoring in the time around infection. The proportion affected by pre-eclampsia amongst participants was not higher than would be expected, although we report a higher than expected proportion affected by eclampsia. There appears to be no effect on birthweight or congenital malformations in women affected by SARS-CoV-2 infection in pregnancy and neonatal infection is uncommon. This study reflects a population with a range of infection severity for SARS-COV-2 in pregnancy, generalisable to whole obstetric populations.


Subject(s)
COVID-19 , Eclampsia , Pre-Eclampsia , Pregnancy Complications, Infectious , Premature Birth , COVID-19/complications , COVID-19/epidemiology , Female , Humans , Infant , Infant, Newborn , Pre-Eclampsia/epidemiology , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Pregnancy Outcome/epidemiology , Premature Birth/epidemiology , Prospective Studies , SARS-CoV-2 , Stillbirth/epidemiology
2.
Scienze Regionali ; 20(3):373-390, 2021.
Article in English | Scopus | ID: covidwho-1548513

ABSTRACT

The current pandemic is a fast moving sequence of events structured around the rate at which human populations become infected through social contact. We chart the pandemic in the UK, showing how the first wave (April 2020) was flat-tened by lockdown through social distancing and working from home. The pandemic reasserted itself in a second wave morphing into a third in December 2020. We examine trajectories relating to how mobility is suppressed by working from home, social dis-tancing, and household mixing. Lastly we explore how key workers commute between different tiers, testing the resilience of the lockdown to spatial interactions. © Società editrice il Mulino.

SELECTION OF CITATIONS
SEARCH DETAIL